Tomoyo H. is a Director, currently leading Medical Affairs Strategy and Communications for the Kite Cell Therapy Franchise at Gilead Sciences. Previously, Tomoyo held various leadership roles in medical affairs at Bayer, including Head of Medical Affairs for GU Oncology and Ra223, and worked as Associate Manager in Ophthalmology and Oncology. Tomoyo also contributed to clinical research and strategic planning at Japan Tobacco Inc. and served as Group Leader for Clinical Development in Gene Therapy at Anges MG, Inc. Tomoyo's extensive background spans roles focused on scientific expertise, strategic planning, and communications in the pharmaceutical industry.
This person is not in any teams
This person is not in any offices